Skip to main content
Premium Trial:

Request an Annual Quote

New Products: InVitae's Hereditary Pancreatic Cancer Test; Enzymatics' Archer FusionPlex; More

Premium

InVitae has launched a hereditary pancreatic cancer panel that covers 17 genes related to pancreatic cancer and the option of adding two genes related to hereditary pancreatitis. The test costs $1,500 in the US and has a turnaround time of three weeks.


Enzymatics has updated its Archer FusionPlex ALK, RET, ROS1 Panel to now include select point mutations in ALK and RET that confer resistance to crizotinib.


MolecularMD, in collaboration with OncoMed, is developing a Notch1 next-generation sequencing-based test. The Notch1 NGS Assay is being developed as a companion diagnostic to identify patients whose cancer may be more likely to benefit from OncoMed's anti-Notch1 antibody, OMP-52M51.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.